“I was really pleased to take part in a clinical trial.”
A study looking at 3 different treatments for kidney cancer (CONSERVE)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This study looked at whether people would consider taking part in a larger trial comparing surgery, radiofrequency ablation (RFA) and cryotherapy. This type of study is called a feasibility study.
This study was supported by Cancer Research UK.
More about this trial
Doctors often use surgery to remove cancer from a kidney. This is called a partial nephrectomy. Although this works well there are risks and complications such as bleeding.
- Radiofrequency ablation (RFA) uses radio waves to destroy the cancer with heat.
- Cryotherapy destroys the cancer by freezing it.
Both these treatments have fewer risks and complications than surgery.
But doctors weren’t sure if they were as good as surgery at getting rid of all the cancer. To find this out researchers needed to compare these 3 treatments in a large randomised trial.
The aims of this study were to find out
- How many people would agree to take part in a randomised trial
- Why people were willing to or not to take part
Summary of results
The study team found that people were unwilling to take part in a randomised trial comparing these 3 treatments.
Of the 74 people asked to join the study, 17 agreed to.
The reasons people gave for not wanting to join the trial included
- a preference for a certain treatment
- seeing some treatments as having either more risks or benefits so they didn’t want to leave the choice to chance
The team gave the people at least 24 hours to consider if they wanted to join. Some people didn’t want to wait that long to make a decision about their treatment.
The study team concluded that the unwillingness of people to join this study should be considered when they design future trials comparing treatments for kidney cancer.
The study team have also used these results to set up the SURAB trial comparing treatments for kidney cancer.
We have based this summary on information from the research team. As far as we are aware, the information they sent us has not been reviewed independently (
How to join a clinical trial
Mr Naeem Soomro
Cancer Research UK
NIHR Clinical Research Network: Cancer
The Newcastle upon Tyne Hospitals NHS Foundation Trust
This is Cancer Research UK trial number CRUK/11/036.